Economic Collapse Report
  • Home
  • About Us
No Result
View All Result
Economic Collapse Report
  • Home
  • About Us
No Result
View All Result
Economic Collapse Report
Home Type Curated

Investors Sue Selena Gomez Over Mental Health Startup

Kimberly Hayek, The Epoch Times by Kimberly Hayek, The Epoch Times
August 15, 2026
in Curated, News
Reading Time: 2 mins read
167 2
0
Selena Gomez

(The Epoch Times)—Singer and actor Selena Gomez was sued Thursday by investors who say the “Only Murders in the Building” star committed fraud by failing to fulfill duties to build and promote her mental health startup.

The plaintiffs invested nearly $1.2 million in Wondermind Global, which was launched in 2021 to help users improve their “mental fitness.”

Investors said they put money into the startup believing that Gomez’s involvement would drive growth. Her role as head of marketing was presented as central, and the sheer size of her social media audience—500 million followers—was part of the pitch.

They argue that Gomez and other company leaders did not deliver any of what they had promised, including a mobile app.

“There was no legitimate enterprise in the works, much less a lucrative one,” the plaintiffs said.

They said the company failed to meet “even its most basic obligations, such as timely paying its employees and vendors.”

The lawsuit maintains that shortfalls left no real business. The investors describe an enterprise that never got off the ground.

Investors said they were assured Gomez would actively promote the venture as head of marketing and “chief impact officer.”

The complaint alleges she signed a contract but largely failed to perform those duties.

“Gomez purported to sign a contract obligating her to perform and then ignored it,” the lawsuit said.

The lawsuit also names Gomez’s mother, Mandy Teefey, a co-chief executive, and former business partner Daniella Pierson as defendants, along with Wondermind Global itself. Court papers allege the defendants overstated the company’s 2022 valuation at $95 million and claimed partnerships with firms such as JPMorgan Chase and Fidelity that never existed.

Plaintiffs maintain they remained unaware of operational shortfalls—including late payments to employees and vendors—until a September 2025 article in The Cut described the company’s collapse and related internal conflicts. Teefey previously disputed aspects of that reporting in a statement to media outlets. Pierson, who departed in 2023, denied the claims against her in a statement to news outlets on Thursday and said she welcomes the chance to present financial records.

Representatives for Gomez and Teefey could not be reached for comment.

Wondermind debuted in 2021 to offer newsletter-based mental health resources. The case was brought in Delaware federal court. It seeks a jury trial, repayment of the nearly $1.2 million investment, additional damages, and attorney fees.

Tags: LedeThe Epoch TimesTop Story
Share81
Tweet51

Related Posts

Anthropic Claude
Curated

Leaked Anthropic IPO Prospectus Shows $42B Net Loss, $518B in Unfunded Spending Commitments, and $20B in Cash

(Zero Hedge)—When Anthropic confidentially submitted its draft S-1 to the SEC back in June, it was clear there were many...

by Tyler Durden, Zero Hedge
September 29, 2026
Copper
Curated

“De-Globalization Endgame”: Deutsche Bank Warns Historic Copper Squeeze Could Ignite 50% Rally

(Zero Hedge)—London copper prices are near record highs at the start of the week, reinforcing the supercycle commodity bull-cycle thesis...

by Tyler Durden, Zero Hedge
September 29, 2026
Next Post
xi-jinping-china-ccp

CCP-Linked AI Rivals US Anthropic’s Model in Cyber Tests

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Original
  • Curated
  • Aggregated
  • News
  • Opinions
  • Videos
  • Podcasts
  • About Us
  • Contact
  • Privacy Policy

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.